Global Clinical Risk Grouping Solutions Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product Type;

Data Analytics, Dashboard & Data Visualization Tools, and Risk Reporting Solutions.

By Deployment;

Public Cloud, Private Cloud, and Hybrid Cloud.

By Application;

Population Health Management, Chronic Disease Management, Clinical Decision Support, Fraud Detection And Prevention, and Others.

By End User;

Healthcare Service Providers, Clinical Research Organizations, Pharmaceutical and Biotech Firms, and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn146905053 Published Date: March, 2025 Updated Date: April, 2025

Introduction

Global Clinical Risk Grouping Solutions Market (USD Million), 2021 - 2031

In the year 2024, the Global Clinical Risk Grouping Solutions Market was valued at USD 729.33 million. The size of this market is expected to increase to USD 1,791.64 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 13.7%.

Clinical Risk Grouping (CRG) solutions are widely recognized for their ability to categorize individuals by utilizing inpatient and outpatient diagnosis and procedure codes, pharmaceutical records, demographic data, and functional health status. This system assigns each person to a specific risk group, aiding in future healthcare projections.

CRG software employs sophisticated clinical logic to categorize patients into distinct risk groups. This grouping mechanism is meticulously organized based on clinical evidence and integrates a comprehensive range of data, including patient history, medical records, administrative data, and more. CRGs encompass individuals of all age groups, including children, adults, and the elderly.

The primary uses of CRGs include analyzing health service utilization patterns, profiling physician practice patterns, identifying new disease trends and occurrences, monitoring the prevalence of chronic or congenital diseases, and adjusting risks for pricing and capitation. CRGs are designed to be patient-centric, focusing on the total disease burden rather than individual diseases, making them suitable for all populations. Additionally, they are instrumental in predicting future healthcare utilization and managing potentially preventable events to enhance overall health status.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product Type
    2. Market Snapshot, By Deployment
    3. Market Snapshot, By Application
    4. Market Snapshot, By End User
    5. Market Snapshot, By Region
  4. Global Clinical Risk Grouping Solutions Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising awareness of risk management in healthcare
        2. Implementation of big data solutions
      2. Restraints
        1. Integration challenges
        2. Data security concerns
      3. Opportunities
        1. Increasing adoption of value-based care models
        2. Growing demand for population health management solutions
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry

  5. Market Segmentation
    1. Global Clinical Risk Grouping Solutions Market, By Product Type, 2021 - 2031 (USD Million)
      1. Data Analytics
      2. Dashboard & Data Visualization Tools
      3. Risk Reporting Solutions
    2. Global Clinical Risk Grouping Solutions Market, By Deployment, 2021 - 2031 (USD Million)
      1. Public Cloud
      2. Private Cloud
      3. Hybrid Cloud
    3. Global Clinical Risk Grouping Solutions Market, By Application, 2021 - 2031 (USD Million)
      1. Population Health Management
      2. Chronic Disease Management
      3. Clinical Decision Support
      4. Fraud Detection And Prevention
      5. Others
    4. Global Clinical Risk Grouping Solutions Market, By End User, 2021 - 2031 (USD Million)
      1. Healthcare Service Providers
      2. Clinical Research Organizations
      3. Pharmaceutical and Biotech Firms
      4. Others
    5. Global Clinical Risk Grouping Solutions Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. 3M Corporation
      2. Optum Inc
      3. Cerner Corporation
      4. Conduent Inc
      5. Nuance Communications
      6. Health Catalyst
  7. Analyst Views
  8. Future Outlook of the Market